| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial
|
Gitelman, Stephen E
|
|
2013
|
1 |
4 |
p. 306-316
11 p.
|
article
|
| 2 |
An unusual case of hypopituitarism
|
Griffiths, Bradley
|
|
2013
|
1 |
4 |
p. e17-
1 p.
|
article
|
| 3 |
A story of a golden boy
|
Cagney, Hannah
|
|
2013
|
1 |
4 |
p. e16-
1 p.
|
article
|
| 4 |
ATG in type 1 diabetes: an unanswered question
|
Skyler, Jay S
|
|
2013
|
1 |
4 |
p. 265-266
2 p.
|
article
|
| 5 |
CABG or PCI for revascularisation in patients with diabetes?
|
Kappetein, Arie Pieter
|
|
2013
|
1 |
4 |
p. 266-268
3 p.
|
article
|
| 6 |
Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials
|
Verma, Subodh
|
|
2013
|
1 |
4 |
p. 317-328
12 p.
|
article
|
| 7 |
Diabetes—a call for research papers
|
Davies, Justine
|
|
2013
|
1 |
4 |
p. 272-
1 p.
|
article
|
| 8 |
Efficacy and safety of recombinant human parathyroid hormone (1–84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study
|
Mannstadt, Michael
|
|
2013
|
1 |
4 |
p. 275-283
9 p.
|
article
|
| 9 |
From synthesis to replacement of parathyroid hormone
|
Linglart, Agnès
|
|
2013
|
1 |
4 |
p. 260-261
2 p.
|
article
|
| 10 |
Immune intervention therapy in type 1 diabetes: safety first
|
Roep, Bart O
|
|
2013
|
1 |
4 |
p. 263-265
3 p.
|
article
|
| 11 |
Improving diabetes care in resource-poor countries: challenges and opportunities
|
Atkinson, Mark A
|
|
2013
|
1 |
4 |
p. 268-270
3 p.
|
article
|
| 12 |
Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
|
Hartemann, Agnès
|
|
2013
|
1 |
4 |
p. 295-305
11 p.
|
article
|
| 13 |
Management of adolescents with congenital adrenal hyperplasia
|
Merke, Deborah P
|
|
2013
|
1 |
4 |
p. 341-352
12 p.
|
article
|
| 14 |
Rajesh Thakker: a man of hidden depths
|
Holmes, David
|
|
2013
|
1 |
4 |
p. 274-
1 p.
|
article
|
| 15 |
Registration and regulation of medical devices used in diabetes in Europe: need for radical reform
|
Boulton, Andrew J M
|
|
2013
|
1 |
4 |
p. 270-272
3 p.
|
article
|
| 16 |
Regulation of glucose homoeostasis by brown adipose tissue
|
Peirce, Vivian
|
|
2013
|
1 |
4 |
p. 353-360
8 p.
|
article
|
| 17 |
Research in brief
|
Kang, Seema
|
|
2013
|
1 |
4 |
p. 273-
1 p.
|
article
|
| 18 |
Restoring immune balance in type 1 diabetes
|
Herold, Kevan C
|
|
2013
|
1 |
4 |
p. 261-263
3 p.
|
article
|
| 19 |
Subclinical and asymptomatic parathyroid disease: implications of emerging data
|
Macfarlane, David P
|
|
2013
|
1 |
4 |
p. 329-340
12 p.
|
article
|
| 20 |
Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial
|
Rigby, Mark R
|
|
2013
|
1 |
4 |
p. 284-294
11 p.
|
article
|
| 21 |
Type 1 diabetes: new year, new future?
|
The Lancet Diabetes & Endocrinology,
|
|
2013
|
1 |
4 |
p. 259-
1 p.
|
article
|
Journal description